Search

Your search keyword '"Navarro, Marta"' showing total 900 results

Search Constraints

Start Over You searched for: Author "Navarro, Marta" Remove constraint Author: "Navarro, Marta"
900 results on '"Navarro, Marta"'

Search Results

1. Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis

2. SYNPA: SMT Performance Analysis and Allocation of Threads to Cores in ARM Processors

4. Identifying risk factors for anal cancer in people with HIV in Spain: a multicentre retrospective cohort study nested in the PISCIS cohort

6. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma

8. Strong chemotaxis by marine bacteria towards polysaccharides is enhanced by the abundant organosulfur compound DMSP

10. Viral infection switches the balance between bacterial and eukaryotic recyclers of organic matter during coccolithophore blooms

16. More than smell – COVID-19 is associated with severe impairment of smell, taste, and chemesthesis

18. La gota preclínica es frecuente en el paciente con enfermedad renal crónica estadio 3-5. Relevancia de la ecografía articular

23. Validation of the antibacterial effect of topically applied tranexamic acid using in vitro and in vivo models

24. Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study

28. Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting

31. Exploring enantiopure zinc-scorpionates as catalysts for the preparation of polylactides, cyclic carbonates, and polycarbonates.

33. Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

34. O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort

35. P28 Drug-induced lupus: clinical and serological features in a tertiary hospital

36. P147 Is belimumab dose optimization possible in patients with systemic lupus erythematosus? Analysis of this therapeutic strategy in a large multicenter cohort of patients from Spanish rheumatology departments

37. P9 Increase of IL10 and INFA2 are associated to clinical activity in systemic lupus erythematous patients

38. P149 Clinical worsening in non-adherent belimumab treatment in SLE

41. Diel variation of seawater volatile organic compounds, DMSP-related compounds, and microbial plankton inside and outside a tropical coral reef ecosystem

43. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study

44. Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases

46. A view of the Brazil-Malvinas confluence, March 2015

49. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

50. Recommendations of the Spanish Rheumatology Society for primary antiphospholipid syndrome. Part II: Obstetric antiphospholipid syndrome and special situations

Catalog

Books, media, physical & digital resources